Structural Heart Disease encompasses a broad spectrum of congenital and acquired abnormalities affecting the heart’s valves, chambers and septal structures. With rapid growth in transcatheter therapies, imaging innovations and multidisciplinary care models, clinicians increasingly seek focused training on Structural Heart Disease when selecting interventional and imaging tracks at a cardiology conference. Because structural disease often progresses silently until advanced dysfunction appears, early recognition, timely intervention and precision-based evaluation are essential components of modern structural heart intervention strategies.

The session begins with an overview of major structural conditions, including aortic stenosis, mitral regurgitation, tricuspid disease, septal defects, patent foramen ovale, hypertrophic obstructive cardiomyopathy and disorders of the left atrial appendage. Participants review how symptoms such as dyspnea, fatigue, syncope, chest pain and edema correspond to underlying pathophysiology, and how disease progression varies across etiologies such as calcification, rheumatic involvement, congenital abnormalities and degenerative aging.

Diagnostic imaging forms the foundation of this programme. Delegates explore transthoracic and transesophageal echocardiography, CT angiography and cardiac MRI to assess valve anatomy, chamber remodeling, gradients, regurgitant volumes and procedural feasibility. Three-dimensional imaging, fusion techniques and dynamic assessment under physiologic stress are highlighted for their value in guiding intervention planning.

The session covers major transcatheter therapies, including TAVR for aortic stenosis, MitraClip and TMVR for mitral disease, and percutaneous tricuspid repair systems. Participants review device selection, anatomical criteria, procedural steps and post-procedural monitoring. Septal interventions such as ASD/PFO closure and alcohol septal ablation are also addressed, with attention to patient selection and hemodynamic impact. Case examples illustrate real-world decision-making in complex anatomies, borderline indications and high-risk surgical candidates.

Multidisciplinary considerations include the role of heart teams, involving interventionalists, cardiac surgeons, imaging specialists, anesthesiologists and geriatricians. Attendees explore risk scoring, frailty assessment, shared decision-making and integration of patient values into procedural planning. The session emphasises how coordinated care improves outcomes, especially in elderly populations or patients with comorbidities such as COPD, renal disease or pulmonary hypertension.

Future directions include next-generation transcatheter valves, repositionable devices, polymer-based prosthetics, AI-guided procedural navigation and fully percutaneous multivalve therapies. Participants also examine expanding indications for earlier intervention based on biomarkers, imaging thresholds and patient symptoms. By the end of this session, clinicians will gain a holistic understanding of structural heart disease evaluation, procedural options and long-term care pathways.